C. Harris

Cancer survivors’ exercise beliefs, knowledge, and behaviors: An Australian National Survey

Sean Stolp, C. Caperchione, M. Agar, 2022, Asia-Pacific journal of clinical oncology.

A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer

I. Marschner, T. Dobbins, R. Ward, 2011 .

Treatment selection for first‐line metastatic renal cell carcinoma in Australia: Impact of new therapy options

A. Joshua, A. Azad, A. Weickhardt, 2019, Asia-Pacific journal of clinical oncology.

Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review.

V. Chin, P. Clingan, M. Aghmesheh, 2022, Immunotherapy.

The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis.

T. Dobbins, R. Ward, C. Harris, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future

L. Kasherman, C. Harris, R. Woodford, 2022, Cancers.

Advances in Treatment Options for Patients with Pancreatic Cancer

D. Goldstein, C. Harris, 2009 .

Tamoxifen use in retroperitoneal fibrosis

D. Goldstein, C. Harris, 2010, Internal medicine journal.

The efficacy of HER 2-targeted agents in metastatic breast cancer : a meta-analysis

T. Dobbins, R. Ward, C. Harris, 2011 .

A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer.

I. Marschner, T. Dobbins, R. Ward, 2011, European journal of cancer.